Trending Now
Agenus (NASDAQ: AGEN) Presents Clinical Data Evaluating AGEN1181 As A Monotherapy...
Agenus (NASDAQ: AGEN) presented new clinical data for AGEN1181 as a monotherapy and in combination with balstiilimab at the 36th Annual Society of Immunotherapy...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
SPY puts on the rise fearing corona virus
Futures are up at the moment but so is the VIX. The SPY is currently sitting at 337.80 in the premarket after...
MAKE IT MODERN
LATEST REVIEWS
Jazz Pharmaceuticals Plc (NASDAQ: JAZZ) Finalizes Supplemental Biologics License Application Submission...
Jazz Pharmaceuticals Plc (NASDAQ: JAZZ) has announced that it has finalized the submission of a supplemental Biologics License Application to the US FDA for...
MAKE IT MODERN
PERFORMANCE TRAINING
Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) Commences Treatment Of COVID-19 Patients With New Antibody Activating Approach
Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) commenced the first phase study investigating a proprietary immunotherapy approach for COVID.19 patients. The new method stimulates a patient's immune...
Sorrento Therapeutics Inc (NASDAQ: SRNE) Doses Its First Patients In Its STI-1558 Study
Sorrento Therapeutics Inc (NASDAQ: SRNE) has announced that it has dosed its first patients in a Phase 1 study for ST1-1558. This viral protease...
Amicus Therapeutics, Inc. (NASDAQ: FOLD) Gets a Patent For Migalasat
Amicus Therapeutics, Inc. (NASDAQ: FOLD) has received a patent from the USPTO for migalastat. The patent, which expires in 2038, covers a compound with...
Novavax, Inc. (NASDAQ: NVAX) Received Marketing Authorization From the Swissmedic
Novavax, Inc. (NASDAQ: NVAX) has received conditional marketing authorisation from the Swissmedic for Nuvaxovid. This compound is a vaccine against COVID-19 in people aged...
SPY puts are yet again on the rise
Futures are down this morning. The SPY is currently sitting at 238.44 in the premarket. In the premarket charts at the moment...
MAKE IT MODERN
